Biogen
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biogen and other ETFs, options, and stocks.About BIIB
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis.
BIIB Key Statistics
BIIB News
Wall Street analysts forecast that Biogen Inc. (BIIB) will report quarterly earnings of $3.45 per share in its upcoming release, pointing to a year-over-year in...
Loading... Loading... Deep-pocketed investors have adopted a bearish approach towards Biogen BIIB, and it's something market players shouldn't ignore. Our trac...
Analysts have lowered their expectations on several global stocks this week by cutting their price targets. The list of stocks includes auto stocks Tesla , Rivi...
Analyst ratings
74%
of 35 ratingsMore BIIB News
Wall Street expects a year-over-year increase in earnings on lower revenues when Biogen Inc. (BIIB) reports results for the quarter ended March 2024. While this...
With a price-to-earnings (or "P/E") ratio of 24.8x Biogen Inc. ( ) may be sending bearish signals at the moment, given that almost half of all companies in the...
